ARTICLE
10 May 2026

Proposed Rule Would Bring Flexibility To Employer Fertility Benefits

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
The U.S. Departments of Labor, Health and Human Services, and Treasury have proposed a new rule that would create a category of limited excepted benefits specifically for fertility treatments, potentially making IVF and other infertility services more accessible and affordable for American workers.
United States Employment and HR
Nick J. Welle’s articles from Foley & Lardner are most popular:
  • with readers working within the Advertising & Public Relations and Banking & Credit industries
Foley & Lardner are most popular:
  • within Wealth Management and Coronavirus (COVID-19) topic(s)

On May 10, 2026, the U.S. Departments of Labor, Health and Human Services (HHS), and the Treasury (collectively, the Departments) announced a proposed rule intended to expand access to fertility benefits by creating a new category of limited excepted benefits. The proposed rule builds on President Trump’s February 18, 2025, Executive Order and other guidance issued by the Trump Administration, which identified a goal of making infertility treatment more accessible and affordable. If finalized, the proposed rule would be effective for plan years beginning on or after January 1, 2027.

A significant number of employer-sponsored major medical plans do not offer fertility benefits or only cover a limited scope of infertility services. In vitro fertilization (IVF) and other infertility services are expensive, with HHS estimating a cost of $10,000-$20,000 for a single IVF cycle.1 The high cost places infertility services out of reach for many Americans. The proposed rule seeks to change this by providing more flexibility for employers seeking to offer fertility benefits to their employees.

Under existing law, offering a carve-out fertility benefit plan is subject to compliance hurdles. Group health plans are generally subject to specific requirements under the Patient Protection and Affordable Care Act (ACA) and other federal laws (market reform requirements). For example, the ACA requires group health plans to provide coverage for certain preventive services. A plan providing limited coverage for a specialized benefit (like fertility benefits) is not able to meet the market reform requirements on a standalone basis.

However, certain types of health benefit plans, known as excepted benefits, are generally excluded from these market reform requirements (e.g., accident-only, hospital indemnity, and certain dental and vision coverage, etc.). The proposed rule would add fertility benefits as a type of excepted benefit that does not need to meet market reform requirements.

Under the proposed rule, for a fertility benefit plan to qualify as a limited excepted benefit, it must:

  • If insured, be provided under a separate policy, certificate, or contract of insurance from major medical coverage;
  • If self-insured, be offered only to employees who have been offered both traditional major medical coverage and the fertility benefit plan by the plan sponsor. The employee is not required to be enrolled in the plan sponsor’s major medical coverage to enroll in the fertility benefit plan;
  • Be limited to benefits substantially all of which are for the diagnosis, mitigation, or treatment of infertility or infertility-related reproductive health conditions and substantially all of which are provided by medical professionals authorized to practice under applicable law;
  • Have a total lifetime benefit of no more than $120,000 per participant (including dependents) (indexed for inflation); and
  • Provide a notice containing specific information to participants that serves as a “quick reference guide” for the benefit.

If finalized, the proposed rule would provide a compliant path for employers that desire to offer fertility benefits to their employees on a carve-out basis. The comment period for the proposed rule ends on July 13, 2026. The Departments have expressly requested input on whether the rule should take immediate effect (rather than a January 1, 2027, effective date), the amount of the lifetime limit, whether the limit should instead be an annual limit, and other comments or data that may provide insight into potential fertility benefit plan design and utilization.

Footnote

1. https://us.pagefreezer.com/en-US/wa/browse/0a7f82bb-be6e-448a-ae11-373d22c37842?find-by-timestamp=2025-01-02T05:49:59Z&url=https:%2F%2Fwww.hhs.gov%2Fabout%2Fnews%2F2024%2F03%2F13%2Ffact-sheet-in-vitro-fertilization-ivf-use-across-united-states.html&timestamp=2025-01-02T07:03:02Z

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More